03692.HK 股價走勢圖
HANSOH PHARMA (03692.HK)
Hansoh Pharmaceutical Group Company Limited
HK$28.76
-1.57%
$-0.45
休市： Jun 25, 16:00:00 HKT
返回
Hansoh Pharmaceutical Group Company Limited (03692.HK)
關鍵數據
前收市價
$29.22
開盤價
$29.66
當日範圍
$28.64 - $29.66
52週區間
$28.06 - $44.22
交易量
11.5M
平均成交量
10.7M
股息收益率
--
每股盈餘 (TTM)
1.08
市值
$174.3B
什麼是 HANSOH PHARMA？
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,347 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.
